Dr. Seshadri is a hematologist-oncologist who specializes in caring for patients with blood cancers, with a particular focus on Hodgkin lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. He has expertise in advanced cancer treatments, such as stem cell transplants, targeted therapies, and immunotherapies, including CAR T-cell therapy. Dr. Seshadri’s research focuses on developing new combinations of immunotherapy and targeted therapies to improve outcomes for patients with lymphoma. He is a principal investigator of multiple ongoing clinical trials and has received several awards for his work. Dr. Seshadri earned his medical degree at Emory University. He completed a residency in internal medicine and fellowship in hematology and oncology at New York Presbyterian Hospital/Weill Cornell Medicine. Dr. Seshadri currently serves on the National Comprehensive Cancer Network's guidelines panel for chronic lymphocytic leukemia.